The potential of alkaloids in drug discovery

Phytotherapy Research

Volumn 15, Issue 3, 2001, Pages 183-205

  Cordell, Geoffrey A ^a   Quinn Beattie, Mary Lou ^a   Farnsworth, Norman R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alkaloids; Biological evaluation; Drug discovery; Future developments; Taxonomic distribution

Indexed keywords

ALKALOID; ATROPINE; BERBERINE; DITERPENE; FLAVONOID; INDOLE; INDOLIZIDINE ALKALOID; ISOQUINOLINE; MORPHINE; NATURAL PRODUCT; PACLITAXEL; PEPTIDE; PIPERIDINE DERIVATIVE; PSEUDOEPHEDRINE; PYRIDINE; PYRROLIDINE DERIVATIVE; PYRROLIZIDINE; QUINIDINE; QUININE; QUINOLINE; QUINOLIZIDINE DERIVATIVE; SESQUITERPENE; TERPENE; TRITERPENE; TROPANE DERIVATIVE; UNINDEXED DRUG; VINBLASTINE; VINCAMINE; VINCRISTINE;

DRUG ACTIVITY; DRUG COST; DRUG STRUCTURE; DRUG USE; EXTRACTION; MEDICINAL PLANT; NONHUMAN; PLANT; REVIEW; TAXONOMY; TRADITIONAL MEDICINE;

ALKALOIDS; DRUG THERAPY; HUMANS; PLANTS, MEDICINAL;

CINCHONA PUBESCENS;

EID: 0034996068     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.890     Document Type: Review

References (168)

1. Abe I, Morita H, Nomura A, Noguchi H 2000. Substrate specificity of chalcone synthase: enzymatic formation of unnatural polyketides from synthetic cinnamoyl-CoA analogues. J Am Chem Soc 122: 11242-11243.
2. Abelson PH 1990. Medicine from plants. Science 247: 513.
3. Ajay Walters WP, Murcko MA 1998. Can we learn to distinguish between drug-like and 'nondrug-like' molecules? J Med Chem 41: 3314-3324.
4. Akerele O, Heywood V, Synge H (eds) 1991. Conservation of Medicinal Plants. Cambridge University Press: Cambridge; 362.
5. Alper KR 2001. Ibogaine: a review. In The Alkaloids: Chemistry and Biology, Volume 56, Alper KR, Glick SD, Cordell GA, (eds). Academic Press: San Diego, in press.
6. Angerhofer CK, Guinaudeau H, Wongpanich V, Pezzuto JM, Cordell GA 1999. Antiplasmodial and cytotoxic activity of natural bisbenzylisoquinoline alkaloids. J Nat Prod 62: 59-66.
7. Angerhofer CK, Konig GM, Wright AD et al. 1992. Selective screening of natural products: a resource for the discovery of novel antimalarial agents. In Advances in Natural Products Chemistry, 8 Atta-ur-Rahman (ed.), Harwood Academic Publishers: Chur, Switzerland; 311-329.
8. Anonymous. 1992a. Biodiversity after UNCED: next steps. WRI/IUCN/UNEP, 3 (2), 1-4.
9. Anonymous. 1992b. Global Biodiversity Strategy, WRI/IUCN/ UNEP: Washington, D.C.; 244.
10. Anonymous 1999. 20 frog species disappear. Chicago Sun Times, April 15, 31.
11. Aszalos A, Frost D 1975. In Methods in Enzymology: Antibiotics. Volume 43. Academic Press: New York; 179-209.
12. Atuegbu A, Maclean D, Nguyen C, Gordon EM, Jacobs JW 1996. Combinatorial modification of natural products: preparation of unencoded and encoded libraries of Rauvolfia alkaloids. Bioorg Med Chem 4: 1097-1106.
13. Badio B, Garraffo HM, Spande TF, Daly JW 1994. Epibatidine: discovery and definition as a potent analgesic and nicotinic agonist. Med Chem Res 4: 440-448.
14. Balandrin MF, Klocke JA, Wurtele ES, Bollinger WH 1985. Natural plant chemicals: sources of industrial and medicinal materials. Science 228: 1154-1160.
15. Balick MJ, Cox PA 1996. Plants, People and Culture. The Science of Ethnobotany. Scientific American Library: New York; 228.
16. Balick MJ, Elisabetsky E, Laird SA (eds) 1996. Medicinal Resources of the Tropical Rain Forest. Biodiversity and Its Importance to Human Health. Columbia University Press: New York, 440.
17. Bannon AW, Decker MW, Holladay MW et al., 1998. Broad-spectrum, non-opioid analgesic activity by selective modulation of Neuronal nicotinic acetylcholine receptors. Science 279: 77-81.
18. Barton DHR 1963. The biogenesis of phenolic alkaloids. Proc Chem Soc Vol. 293-299.
19. Barton DHR, Bhakuni DS, Chapman GM, Kirby GW 1966. The biosynthesis of roemerine, anonaine and mecambrine. Chem Commun 259-260.
20. Beutler JA, McKee TC, Fuller RW et al. 1993. Frequent occurrence of HIV-inhibitory sulphated polysaccharides in marine invertebrates. Antiviral Chem Chemother 4: 167-172.
21. Bhat L, Liu Y, Victory SF, Himes RH, Georg GI 1998. Synthesis and evaluation of paclitaxel C7 derivatives: solution phase synthesis of combinatorial libraries. Bioorg Med Chem Lett 8: 3181-3186.
22. Bindra JS, Bindra R 1975. Creativity in Organic Synthesis, Volume 1 Academic Press New York; 322.
23. Borman S 1998a. End run around FDA? Chem Eng News, June 1, 45-47.
24. Borman S 1998b. Biosynthesis combinatorially. Chem Eng News, September 14, 29-30.
25. Borman S 1999a. Reducing the time to drug discovery. Chem Eng News, March 8, 33-48.
26. Borman S 1999b. Genomics rises to drug discovery challenge. Chem Eng News, April 19, 59-67.
27. Borman S 2000. Combinatorial chemistry. Redefining the scientific method. Chem Eng News May 15, 53-65.
28. Bruneton J 1993. Pharmacognosy, Phytochemistry, Medicinal Plants, Lavoisier: Paris; 915.
29. Buolamwimi JK 2000. Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des 6: 379-392.
30. Bureau of the Census, Department of Commerce 2000. The World Almanac and Book of Facts, 2001. World Almanac Books; Mahwah, N.J., 861-862.
31. Clark AM 1996. Natural products as a resource for new drugs. Pharm Res 13: 1133-1141.
32. Cordell GA 1981. Introduction to Alkaloids - A Biogenetic Approach. Wiley-lnterscience: New York; 1055.
33. Cordell GA 1987. Pharmacognosy - far from dead. Am Druggist March, 96-98.
34. Cordell GA 1990a. Pharmacognosy - a high tech pharmaceutical science. Pharmacia 30: 169-181.
35. Cordell GA 1990b. Pharmacognosy - the high tech pharmaceutical science. In Proceedings of the Second International Symposium on Recent Advances in Natural Products Research, Lee EB, Shin KH, Kang SS, Han YN (eds). Natural Products Research Institute, Seoul National University: Seoul, Korea; 24-40.
36. Cordell GA 1992. Not for us, but for our descendants. Thai J Pharm Sci 16: 1-3.
37. Cordell GA 1993. Pharmacognosy - new roots for an old science. In Studies in Natural Products Chemistry, Volume 13. Bioactive Natural Products (Part A), Atta-ur-Rahman, Basha FZ (eds). Elsevier Science Publishers: Amsterdam, 629-675.
38. Cordell GA 1995a. Natural products as medicinal and biological agents. Potentiating the resources of the rain forest. In Chemistry of the Amazon, ACS Symposium Series, No. 588, Seidel PF, Gottlieb OR, Colho Kaplan MA (eds). American Chemical Society: Washington, D. C.; 8-18.
39. Cordell GA 1995b. Changing strategies in natural product chemistry. Phytochemistry 40: 1585-1612.
40. Cordell GA 2000. Biodiversity and drug discovery - a symbiotic relationship. Phytochemistry 55: 463-480.
41. Cordell GA 2001. Perspectives on the future role of plants in drug discovery, In Proceedings of the Fourth Princess Chulabhorn International Science Congress, Ruchirawat SS, Mongulsuk S, Ruchirawat M (eds). Chulabhorn Research Institute: Bangkok, Thailand, in press.
42. Cordell GA, Angerhofer CK, Pezzuto JM 1994. Recent studies on cytotoxic, anti-HIV, and antimalarial agents from plants. Pure Appl Chem 66: 2283-2286.
43. Cordell GA, Araujo OE 1993. Capsaicin: identification, nomenclature and pharmacotherapy. Ann Pharmacother 27: 330-336.
44. Cordell GA, Beecher CWW, Pezzuto JM 1991. Can ethnopharmacology contribute to the development of new anticancer drugs? J Ethnopharmacol 32: 117-133.
45. Cordell GA, Beecher CWW, Kinghorn AD et al. 1997. The dereplication of natural products. In Studies in Natural Products Chemistry, Volume 19, Atta-ur-Rahman (ed.), Elsevier Science Publishers; Amsterdam, 749-791.
46. Cordell GA, Beecher CWW, Farnsworth NR et al., 1998. Recent studies on biologically active natural products. In New Trends in Natural Product Chemistry, Atta-ur-Rahman, Chaudhary MI (eds). Harwood Academic Publishers; Chur, Switzerland; 57-78.
47. Cordell GA, Shin YG 1999. Finding the needle in the haystack. The dereplication of natural product extracts. Pure Appl Chem 71: 1089-1094.
48. Corley DG, Durley RC 1994. Strategies for database dereplication of natural products. J Nat Prod 57: 1484-1490.
49. Cox PA 2000. Will tribal knowledge survive the millennium? Science 287: January 7, 44-45.
50. Cox PA, Balick MJ 1994. The ethnobotanical approach to drug discovery. Sci Amer June, 82-87.
51. Cragg GM, Baker JT, Borris RP, et al. 1997a. Interactions with source countries. Guidelines for members of the American Society of Pharmacognosy. J Nat Prod 60: 654-655.
52. Cragg GM, Boyd MR 1996. Drug discovery and development at the National Cancer Institute: The role of natural products of plant origin. In Medicinal Resources of the Tropical Rain Forest. Biodiversity and Its Importance to Human Health, Balick MJ, Elisabetsky E, Laird SA (eds). Columbia University Press; New York; 101-136.
53. Cragg GM, Newman DJ, Snader KM 1997b. Natural products in drug discovery and development. J Nat Prod 60: 52-60.
54. Cronquist A 1981. An Integrated System of Classification of Flowering Plants. Columbia University Press; New York; 1262.
55. Cummins DJ, Andrews CW, Bentley JA, Cory M 1996. Molecular diversity in chemical databases: comparison of medicinal chemistry knowledge bases and databases of commercially available compounds. J Chem Inf Comput Sci 36: 750-763.
56. Dalton DR 1979. The Alkaloids. The Fundamental Chemistry. Marcel Dekker: New York; 789.
57. Daly JW 1998. The nature and origin of amphibian alkaloids. In The Alkaloids: Chemistry and Biology, Volume 50. Cordell GA, (ed.). Academic Press: San Diego, CA; 141-169.
58. Daly JW, Brown GB, Mensah-Dwumah M, Myers CW 1978. Classification of skin alkaloids from neotropical poison-dart frogs (Dendrobatidae). Toxicon 16: 163-188.
59. Daly JW, Garraffo HM, Myers CW 1997. The origin of frog skin alkaloids: an enigma. Pharmaceut News 4(4): 9-14.
60. Daly JW, Garraffo HM, Spande TF 1993. Amphibian alkaloids. In The Alkaloids: Chemistry and Pharmacology, Volume 43. Cordell GA (ed.). Academic Press: San Diego, CA; 185-288.
61. Daly JW, Garraffo HM, Spande TF, Decker MW, Sullivan JP, Williams M 2000. Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics. Nat Prod Rep 17: 131-135.
62. De Smet PAGM 1997. The role of plant-derived drugs from plants and herbal medicines. Drugs 54: 802-840.
63. Dev S 1999. Ancient-modern concordance in Ayurvedic plants: some examples. Res Rev Environ Hlth Persp 107: 783-789.
64. Dittrich H, Kutchan TM 1991. Molecular cloning, expression, and induction of berberine bridge enzyme, an enzyme essential to the formation of benzophenanthridine alkaloids in the response of plants to pathogenic attack. Proc Natl Acad Sci 88: 9969-9973.
65. Dolle RE, Nelson Jr, KH 1999. Comprehensive survey of combinatorial library synthesis: 1998. J Comb Chem 1: 235-282.
66. Donadio S, Staver MJ, McAlpine JB, Swanson SJ, Katz L. 1991. Modular organization of genes required for complex polyketide biosynthesis. Science 252: 675-679.
67. Erenfeld D 1988. Why put a value on biodiversity? In Biodiversity, Wilson EO (ed.). National Academy Press: Washington, D.C.; 212-216.
68. Ehrlich PR 1988. The loss of diversity: causes and consequences. In Biodiversity, Wilson EO, (ed.). National Academy Press: Washington, D.C.; 21-27.
69. Eisenberg D, Marcotte E, Xenarios I, Yeates T 2000. Protein function in the post-genomic era. Nature 405: 823-826.
70. Endicott JA, Ling V 1989. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171.
71. Evans J 1999. Call out the reserves. Chem Brit August, 38-41.
72. Fannon MR 1996. Gene expression in normal and disease states - identification of therapeutic targets. Trends Biotechnol 14: 294-298.
73. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z 1985. Medicinal plants in therapy. Bull WHO 63: 965-981.
74. Farnsworth NR, Morris RW 1976. Higher plants - the sleeping giant of drug development. Am J Pharm 147: 46-52.
75. Fernandez JW, Fernandez RL 2001. "Returning to the path": The use of iboga(ine) in an Equatorial African ritual context and the binding of time, space, and social relationships. In The Alkaloids: Chemistry and Biology, Volume 56, Alper KR, Glick SD, Cordell GA (eds). Academic Press, San Diego, in press.
76. Floyd CD, Leblanc C, Whittaker M 1999. Combinatorial chemistry as a tool for drug discovery. Prog Med Chem 36: 91-168.
77. Foye WO 1995. Medicinals of plant origin: historical aspects. In Principles of Medicinal Chemistry, Foye WO, Lemke TL, Williams DA (eds). Williams and Wilkins: Baltimore, MD; 7-11.
78. Frick S, Ounaroon A, Kutchan TM 2001. Combinatorial biochemistry in plants: the case of O-methyl transferases. Phytochemistry 56: 1-4.
79. Gaffield W 2000. The Veratrum alkaloids: natural tools for studying embryonic development. In Studies in Natural Products Chemistry, Volume 23, Bioactive Natural Products (Pan D), Atta-ur-Rahman (ed.), Elsevier Science Publishers; Amsterdam, 563-589.
80. Goodman J 1994. Tobacco in History: The Culture of Dependence. Routledge; London; 280.
81. Grabley S, Thiericke R, Sattler I 2000. Tools for drug discovery: natural product based libraries. Ernst Schering Research Foundation Workshop. Springer-Verlag; Berlin, 217-252.
82. Grifo F, Newman D, Fairfield AS, Bhattacharya B, Grupenho JT 1997. The origins of prescription drugs. In Biodiversity and Human Health, Grifo F, Rosenthal J, (eds). Island Press: Washington, DC; 131-163.
83. Hamburger MO, Hostettmann K 1991. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry 30: 3864-3874.
84. Hamill JD, Robins RJ, Parr AJ, Evans DM, Furze JM, Rhodes MJC 1990 Over-expressing a yeast ornithine decarboxylase gene in transgenic roots of Nicotiana rustica can lead toenhnaced nicotine accumulation. Plant Mol Biol 15: 27-38.
85. Hashimoto T, Yun DJ, Yamada Y 1993. Production of tropane alkaloids in genetically engineered root cultures. Phytochemistry 32: 713-718.
86. Hatfield GM 1979. Toxic mushrooms. In Toxic Plants, Kinghorn AD (ed.). Columbia University Press: New York; 7-58.
87. Hehlmann R, Hochhaus A, Berger U, Reiter A 2000. Current trends in the management of chronic myelogenous leukemia. Ann Hematol 79: 345-354.
88. Henkel T, Brunne RM, Müller H, Reichel F 1999. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed 38: 643-647.
89. Henry CM 2000. Antibiotic resistance. Chem Eng News, March 6, 41-58.
90. Hesse M 1978. Alkaloid Chemistry Wiley-Interscience: New York, 231.
91. Hsiang Y-H, Hertzberg R, Hecht S, Liu LF 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260: 14873-14878.
92. Hsiang Y-H, Liu LF 1988. Identification of mammalian topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48: 1722-1726.
93. Ikan R 1991. Natural Products. A Laboratory Guide. 2nd edn. Academic Press: San Diego, CA; 360.
94. Johnston BA 1998. Major diversity loss: 1 in 8 plants in global study threatened. HerbalGram 43: 54.
95. Keeler RF, Baker DC, Gaffield W 1991. Teratogenic Solanum species and the responsible teratogens. In Toxicology of Plant and Fungal Compounds. Handbook of Natural Toxins, Volume 6. Keeler RF, Tu AT (eds). Marcel Dekker, Inc.: New York; 83-99.
96. Kigodi PGK, Blaskó G, Thebtaranonth Y, Pezzuto JM, Cordell GA 1989. Spectroscopic and biological investigation of nimbolide and 28-deoxonimbolide from Azadirachta indica. J Nat Prod 52: 1246-1251.
97. Kim H-Y, Park S-W, Park J-N, Moon K-H, Lee C-K 1995. Screening and isolation of antibiotic resistance inhibitors from herb materials. I. Resistance inhibition of 21 Korean plants. Nat Prod Sci 1: 50-54.
98. Kozikowski AP, Campiani G, Sun L-Q, Wang S-M, Saxena A, Doctor BP 1996. Identification of a more potent analogue of the naturally occurring alkaloid huperzine A. Predictive molecular modeling of its interaction with AChE. J Am Chem Soc 118: 11357-11362.
99. Kushiro T, Shibuya M, Masuda K, Ebizuka Y 2000. Mutational studies on triterpene syntheses: engineering lupeol synthase into β-amyrin synthase. J Am Chem Soc 122: 6816-6824.
100. Kutchan TM 1998. Molecular genetics of alkaloid biosynthesis. In The Alkaloids: Chemistry and Biology, Cordell GA, (ed.) Academic Press: San Diego; 257-316.
101. Kutchan TM, Dittrich H 1995. Characterization and mechanism of the berberine bridge enzyme, a covalently flavinylated oxidase of benzophenanthridine biosynthesis in plants. J Biol Chem 270: 24475-24481.
102. Levitt J 2000. Letter and Outline on Dietary Supplement Strategy, Ten Year Plan. Center for Food Safety and Applied Nutrition, Food and Drug Administration: Washington, DC; 1-6.
103. Lewis WH, Elvin-Lewis MP 1995. Medicinal plants as sources of new therapeutics. Ann Miss Bot Gard 82: 16-24.
104. Likhitwitayawuid K, Angerhofer CK, Cordell GA, Pezzuto JM, Ruangrungsi N. 1993a. Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Stephania erecta. J Nat Prod 56: 30-38.
105. Likhitwitayawuid K, Angerhofer CK, Chai H-B, Pezzuto JM, Cordell GA, Ruangrungsi N 1993b. Cytotoxic and antimalarial alkaloids from the bulbs of Crinum amabile. J Nat Prod 56: 1331-1338.
106. Likhitwitayawuid K, Angerhofer CK, Chai H-B, Pezzuto JM, Cordell GA, Ruangrungsi N 1993c. Cytotoxic and antimalarial alkaloids from the bulbs of Stephania pierrei. J Nat Prod 56: 1468-147.
107. Lin L-Z, Shieh H-L, Angerhofer CK et al. 1993. Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Cyclea barbata. J Nat Prod 56: 22-29.
108. Lipinski CJ, Lombardo F, Dominy BW, Feeney PJ 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Disc Revs 23: 3-25.
109. Lister DL, Rathbone D, Bruce N 2001. Biotransformation of alkaloids. The Alkaloids: Chemistry and Biology, Volume 57 Academic Press; San Diego, in press.
110. Lister DL, Kanungo G, Rathbone DA, Bruce NC 1999. Transformation sof codeine to important semisynthetic opiate derivatives by Pseudomonas putida m10. FEMS Microbiol Lett 181: 137-144.
111. Liu J-S, Zhu Y-L, Yu C-M et al. 1986. The structures o huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Can J Chem 64: 837-839.
112. Lockhart DJ, Winzeler EA 2000. Genomics, gene expression and DNA arrays. Nature 405: 827-836.
113. Loub WD, Farnsworth NR, Soejarto DD, Quinn ML 1985. NAPRALERT: Computer-handling of Natural Product Research Data. J Inf Comp Sci 25: 99-103.
114. Lugo AE 1988. Estimating the reductions in the diversity of tropical forest species. In Biodiversity, Wilson EO, (ed.). National Academy Press; Washington, DC; 58-70.
115. Mabberley DJ 1987. The Plant Book. Cambridge University Press; Cambridge; 707.
116. Mattocks AR 1986. Chemistry and Toxicology of Pyrrolizidine Alkaloids Academic Press: London; 391.
117. McDonald KA 1997. Destined for extinction. Chronicle of Higher Education, November 74, A17.
118. Mendelsohn R, Balick MJ 1995. The value of undiscovered pharmaceuticals in tropical forests. Econ Bot 49: 223-228.
119. Moriguchi I, Hirono S, Liu Q, Nakagome Y, Matsushita Y 1992. Simple method of calculating octanol/water partition coefficient. Chem Pharm Bull 40: 127-130.
120. Mosher HS 1986. Tetrodotoxin, saxitoxin and the molecular biology of the sodium channel. Ann N Y Acad Sci 479: 1-448.
121. Mossinghoff GJ 1992-2000. New Drug Approvals. Pharmaceutical Manufacturers Association: Washington, DC.
122. Newman DJ, Cragg GM, Snader KM 2000. The influence of natural products upon drug discovery. Nat Prod Rep 17: 215-234.
123. Nicolau KC, Pfefferkorn JA, Roecker AJ, Cao G-Q, Barluenga S, Mitchell HJ. 2000. Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans. J Am Chem Soc 122: 9939-9953.
124. Oldfield ML 1989. The Value of Conserving Genetic Resources. Sinauer Associates: Sunderland, MA.
125. O'Neill MJ, Bray DH, Boardman P et al. 1988. Plants as sources of antimalarial drugs, part 6: activities of Soulamea amara fruits. J Ethnopharmacol 22: 183-190.
126. O'Neill MJ, Lewis JA 1993. The renaissance of plant research in the pharmaceutical industry. In Human Medicinal Agents from Plants: ACS Symposium Series 534, Kinghorn AD, Balandrin MF, (eds). American Chemical Society: Washington, DC; 48-55.
127. Pal K 2000. The keys to chemical genomics. Mod Drug Disc September, 47-55.
128. Pauli HH, Kutchan TM 1998. Molecular cloning and functional heterologous expression of two alleles encoding (S)-N-methylcoclaurine 3′-hydroxylase (CYP80B1), a new methyl jasmonate-inducible cytochrome P-450-dependent mono-oxygenase of benzylisoquinoline alkaloid biosynthesis. Plant J 13: 793-801.
129. Pelletier SW 1983. The nature and definition of an alkaloid. Alkaloids: Chemical and Biological Perspectives, Volume 1. Pelletier SW, (ed.). Wiley-Interscience: New York; 1-31.
130. Pettit GR, Pettit III GR, Groszek G, Backhaus RA, Doubek DL, Barr RJ 1995. Antineoplastic agents, 301. An investigation of the Amaryllidaceae genus Hymenocallis. J Nat Prod 58: 756-759.
131. Phillipson JD, Wright CW 1991. Can ethnopharmacology contribute to the development of antimalarial agents? J Ethnopharmacol 32: 155-165.
132. Potmesil M, Pinedo H, (eds) 1985. Camptothecins: New Anticancer Agents. CRC Press: Boca Raton, FL. 149.
133. Principe PP 1991. Valuing the biodiversity of medicinal plants. In Conservation of Medicinal Plants, Akerele O, Heywood V, Synge H, (eds). Cambridge University Press; Cambridge; 79-124.
134. Principe PP 1996. Monetizing the pharmacological benefits of plants. In Medicinal Resources of the Tropical Rainforest, Balick MJ, Elizabetsky E, Laird S, (eds). Columbia University Press: New York; 191-218.
135. Quimme P 1976. The Signet Book of Coffee and Tea. New American Library: New York, 242.
136. Raven PH 1988. Our diminishing tropical forests, In Biodiversity, Wilson EO, (ed.). National Academy Press: Washington, DC; 119-122.
137. Roberts MF, Wink M 1998. Introduction. In Alkaloids: Biochemistry, Ecology, and Medicinal Applications, Roberts MF, Wink M, (eds). Plenum Press: New York; 1-7.
138. Roduit JP, Wellig A, Kerner A 1997. Renewable functionalized pyridines derived from microbial metabolites of the alkaloid (S)-nicotine. Heterocycles 45: 1687-1702.
139. Rumsfeld JA, West DP 1991. Topical capsaicin in dermatologic and peripheral pain disorders. Drug Intell Clin Pharm 25: 381-387.
140. Saifah E, Puripattanavong J, Likhitwitayawuid K, Cordell GA, Chai H-B, Pezzuto JM. 1993. Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. J Nat Prod 56: 473-477.
141. Schmeller T, Wink M 1998. Utilization of alkaloids in modern medicine. In Alkaloids: Biochemistry, Ecology, and Medicinal Applications, Roberts MF, Wink M, (eds). Plenum Press: New York; 435-459.
142. Schmid I, Sattler I, Grabley S, Thiericke R 1999. Natural products in high throughput screening: automated high-quality sample preparation. J Biomol Screen 4: 15-25.
143. Skolnick AA 1997. Old Chinese herbal medicine used for fever yields possible new Alzheimer's disease therapy. J Am Med Assoc 227: 776.
144. Soejarto DD, Farnsworth NR 1989. Tropical rainforests: potential source of new drugs? Persp Biol Med 32: 244-256.
145. Song C-E 2000. Alkaloids as chirality transmitters in asymmetric catalysis. In The Alkaloids: Chemistry and Biology, Volume 53, Cordell GA, (ed.). Academic Press; San Diego, CA; 1-56.
146. Spande TF, Garraffo HM, Edwards MW, Yeh HJC, Pannell L, Daly JW 1992. Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadorean poison frog. J Am Chem Soc 114: 3475-3478.
147. Steffens P, Nagakura N, Zenk MH 1985. Purification and characterization of the berberine bridge enzyme from Berberis beaniana cultures. Photochemistry 24: 2577-2583.
148. Sun CM 1999. Recent advances in liquid-phase combinatorial synthesis. Comb Chem High Throughput Screen 2: 299-318.
149. Suffness M (ed.) 1995. Taxol: Science and Applications. CRC Press: Boca Raton, FL; 426.
150. Szántay Cs 1995. Synthetic studies in alkaloid chemistry. In The Alkaloids: Chemistry and Biology, Volume 50, Cordell GA (ed.). Academic Press: San Diego; 377-414.
151. Tang W, Eisenbrand G 1992. Chinese Drugs of Plant Origin. Springer-Verlag: Berlin; 1056.
152. Taylor WI, Farnsworth NR (eds) 1973. The Catharanthus Alkaloids, Botany, Chemistry and Pharmacology. Marcel Dekker; New York; 323.
153. Torssell KBG 1997. Natural Product Chemistry. Apotekarsocieteten, Swedish Pharmaceutical Press: Stockholm, 480.
154. Verpoorte R, van der Heijden R, Memelink J 1998. Plant biotechnology and the production of alkaloids: prospects for metabolic engineering. In The Alkaloids: Chemistry and Biology, Volume 50. Cordell GA, (ed.). Academic Press; San Diego, CA; 453-508.
155. Vogel VJ 1990. American Indian Medicine. University of Oklahoma Press; Stillwater, OK; 632.
156. Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA 1966. Plant antitumor agents I. The isolation and structure elucidation of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 88: 3888-3890.
157. Walton NJ 1992. A fine chemical harvest. Chem Brit. 525-529.
158. Warr WA 1997. Combinatorial chemistry and molecular diversity. An overview. J Chem Inf Comput Sci 37: 134-140.
159. Waterman PG 1998. Chemical taxonomy of alkaloids. In Alkaloids: Biochemistry, Ecology, and Medicinal Applications. Roberts MF, Wink M, (eds). Plenum Press; New York; 87-107.
160. Wilson EO 1988. The current state of biological diversity. In Biodiversity. Wilson EO, (ed.). National Academy Press; Washington, DC; 3-18.
161. Wink M 1998. Chemical ecology of alkaloids. In Alkaloids: Biochemistry, Ecology, and Medicinal Applications Roberts MF, Wink M, (ed.). Plenum Press; New York; 265-300.
162. Wink M 2000. Interference of alkaloids with neuroreceptors and ion channels. In Studies in Natural Products Chemistry, Volume 21, Atta-ur-Rahman (ed.). Elsevier Science: The Netherlands; 3-122.
163. Wink M, Roberts MF 1998. Compartmentation of alkaloid synthesis, transport and storage. In Alkaloids: Biochemistry, Ecology, and Medicinal Applications. Roberts MF, Wink M, (ed.) Plenum Press: New York; 239-262.
164. Xiao X-Y, Parandoosh Z, Nova MP 1997. Design and synthesis of a taxoid library using radiofrequency encoded combinatorial chemistry. J Org Chem 62: 6029-6033.
165. You M, Cordell GA, Pezzuto JM 2001. Reversal of P-glycoprotein-mediated multidrug resistance in human KB carcinoma cells by the antitumor alkaloid acronycine. In preparation.
166. You M, Ma X-J, Mukherjee R et al. 1994. Indole alkaloids from Peschiera laeta that enhance vinblastine-mediated cytotoxicity with multidrug-resistant cells. J Nat Prod 57: 1517-1522.
167. You M, Wickramaratne DBM, Silva GI et al. 1995. (-)-Roemerine, an aporphine alkaloid from Annona senegalensis that reverses the multidrug-resistance phenotype with cultured cells. J Nat Prod 58: 598-604.
168. Yu T-W, Shen Y, McDaniel R et al. 1998. Engineered biosynthesis of novel polyketides from Streptomyces spore pigment polyketide syntheses. J Am Chem Soc 120: 7749-7759.